CBC has shown promise in providing neuroprotection, which refers to its ability to protect and support the health of neurons in the brain. Studies have indicated that CBC may have anti-inflammatory and antioxidant properties that can help mitigate damage to brain cells and potentially reduce the risk of neurological disorders.

Cannabichromene (CBC) has shown potential in promoting neurogenesis, the growth of new brain cells. This process involves enhancing the viability and development of brain cells. While research is still in its early stages, these findings suggest that CBC may have neuroprotective and regenerative effects on the brain.

CBC has demonstrated the ability to block pain and inhibit inflammation related to collagen-induced osteoarthritis. Unlike non-steroidal anti-inflammatory drugs (NSAIDs), CBC works on inflammation in a different manner and appears to lack the associated side effects of these medications. Promising research suggests that CBC could offer a potential alternative for managing pain and inflammation

Though discovered almost half a century ago, it was in 2006 that researchers found promising evidence of CBC as a potential cancer-fighting agent. In a study exploring the effects of cannabinoids on cancer, CBC was identified as the second most effective cannabinoid, after CBG, in inhibiting the growth of new cancer cells. This discovery highlights CBC's potential as a powerful compound to be further explored in the development of anti-cancer therapies.